Request Copyright Permission

Connected Inhalers and Digital Health in the USA: Regulatory Perspectives

Lee JJ.

Respiratory Drug Delivery 2020. Volume 1, 2020: 271-272.


The FDA’s Center for Devices and Radiological Health (CDRH) has established the Digital Health program, which seeks to better protect and promote public health and provide continued regulatory clarity by:

• Fostering collaborations and enhancing outreach to digital health customers, and

• Developing and implementing regulatory strategies and policies for digital health technologies.

This presentation will address current regulatory perspectives on connected inhalers and digital health in the USA.

I have a subscription

Log in for instant access.

Forgotten Password?

I do not have a subscription

Purchase Article (in PDF format)

Ordering from RDD Online

Add To Cart $35

↑ Back to Top